Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.

  • Authors : Marino-Enriquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Dec 15; Vol. 29 (24), pp. 5128-5139.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265

Record details

×
Academic Journal

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.

  • Authors : Schaefer IM; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Lundberg MZ

  • Source: Cancer [Cancer] 2021 Aug 01; Vol. 127 (15), pp. 2666-2673. Date of Electronic Publication: 2021 Mar 31.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Editorial & Opinion

Cancer Survivorship-Considering Mindsets-Reply.

  • Authors : Baker LH; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.; Sarcoma Survivorship Program, University of Michigan, Ann Arbor.

  • Source: JAMA oncology [JAMA Oncol] 2020 Sep 01; Vol. 6 (9), pp. 1469.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cancer Survivorship-A Call to Action.

  • Authors : Baker LH; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.

  • Source: JAMA oncology [JAMA Oncol] 2020 May 01; Vol. 6 (5), pp. 632-633.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study.

  • Authors : Baker LH; Department Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Boonstra PS

  • Source: Journal of cancer metastasis and treatment [J Cancer Metastasis Treat] 2020; Vol. 6. Date of Electronic Publication: 2020 Aug 07.Publisher: OAE Publishing Inc Country of Publication: United States NLM ID: 101697513 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

The necessity for rigour in rare disease study design.

  • Authors : Baker LH; Department Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA. Electronic address: .

  • Source: The Lancet. Oncology [Lancet Oncol] 2019 Sep; Vol. 20 (9), pp. 1190-1192. Date of Electronic Publication: 2019 Jul 19.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In Memoriam: Charles A. Coltman, 1930 to 2018.

  • Source: Journal of Clinical Oncology; 5/1/2019, Vol. 37 Issue 13, p1037-1040, 5p

Record details

×
Academic Journal

Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices.

  • Authors : Ramsey SD; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Unger JM

  • Source: JAMA oncology [JAMA Oncol] 2019 Apr 01; Vol. 5 (4), pp. 497-505.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases.

  • Authors : Siontis BL; Department of Internal Medicine, University of Michigan, 1500 E Medical Center Drive, Ann Arbor, MI 48109, USA.; Department of Medical Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55901, USA.

  • Source: Sarcoma [Sarcoma] 2019 Mar 10; Vol. 2019, pp. 1960593. Date of Electronic Publication: 2019 Mar 10 (Print Publication: 2019).Publisher: Hindawi Publishing Country of Publication: Egypt NLM ID: 9709257 Publication Model: eCollection Cited Medium: Print ISSN: 1357-714X

Record details

×
Academic Journal

Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.

  • Source: JAMA oncology [JAMA Oncol] 2018 Jun 01; Vol. 4 (6), pp. 814-820.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

  • Authors : Tawbi HA; University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: .; Burgess M

  • Source: The Lancet. Oncology [Lancet Oncol] 2017 Nov; Vol. 18 (11), pp. 1493-1501. Date of Electronic Publication: 2017 Oct 04.Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Integrative clinical genomics of metastatic cancer.

  • Authors : Robinson DR; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.; Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA.

  • Source: Nature [Nature] 2017 Aug 17; Vol. 548 (7667), pp. 297-303. Date of Electronic Publication: 2017 Aug 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Reduced infectivity of waterborne viable but nonculturable Helicobacter pylori strain SS1 in mice.

  • Authors : Boehnke KF; Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA.; Eaton KA

  • Source: Helicobacter [Helicobacter] 2017 Aug; Vol. 22 (4). Date of Electronic Publication: 2017 Apr 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.

  • Authors : Heinrich MC; Division of Hematology and Medical Oncology, Portland Veterans Affairs Health Care System, Knight Cancer Institute, Oregon Health and Science University, Portland.; Rankin C

  • Source: JAMA oncology [JAMA Oncol] 2017 Jul 01; Vol. 3 (7), pp. 944-952.Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Next generation sequencing of extraskeletal myxoid chondrosarcoma.

  • Authors : Davis EJ; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.; Wu YM

  • Source: Oncotarget [Oncotarget] 2017 Mar 28; Vol. 8 (13), pp. 21770-21777.Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru.

  • Source: Infection and drug resistance [Infect Drug Resist] 2017 Mar 10; Vol. 10, pp. 85-90. Date of Electronic Publication: 2017 Mar 10 (Print Publication: 2017).Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550216 Publication Model: eCollection Cited Medium: Print ISSN:

Record details

×
Academic Journal

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.

  • Source: Cancer [Cancer] 2017 Jan 01; Vol. 123 (1), pp. 90-97. Date of Electronic Publication: 2016 Oct 03.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Academic Journal

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

  • Authors : Koshkin VS; Vadim S. Koshkin, Cleveland Clinic, Cleveland, OH; Vanessa Bolejack, Cancer Research and Biostatistics, Seattle, WA

  • Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2016 Oct 20; Vol. 34 (30), pp. 3680-3685.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

The University of Michigan Sarcoma Survivorship Clinic: Preventing, Diagnosing, and Treating Chronic Illness for Improved Survival and Long-Term Health.

  • Authors : Bobowski NP; Department of Internal Medicine, University of Michigan Sarcoma Survivorship Program , Ann Arbor, Michigan.; Baker LH

  • Source: Journal of adolescent and young adult oncology [J Adolesc Young Adult Oncol] 2016 Sep; Vol. 5 (3), pp. 211-4. Date of Electronic Publication: 2016 Apr 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101543508 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
  • 1-25 of  527 results for ""BAKER, LAURENCE H.""